New Results from Second Phase 3 Study Show Significant Efficacy of Guselkumab and Superiority versus Humira in Treatment of Moderate to Severe Plaque Psoriasis

Additional Phase 3 Study Data Show Significant Efficacy of Guselkumab in Patients Experiencing Inadequate Response to STELARAÂ in the Treatment of Moderate to Severe Plaque Psoriasis Janssen Research & Development LLC Jan...